Castle Biosciences Inc
NASDAQ:CSTL

Watchlist Manager
Castle Biosciences Inc Logo
Castle Biosciences Inc
NASDAQ:CSTL
Watchlist
Price: 31.79 USD -0.03%
Market Cap: 881.9m USD
Have any thoughts about
Castle Biosciences Inc?
Write Note

Intrinsic Value

CSTL's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

The intrinsic value of one CSTL stock under the Base Case scenario is 32.02 USD. Compared to the current market price of 31.79 USD, Castle Biosciences Inc is Undervalued by 1%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

CSTL Intrinsic Value
32.02 USD
Undervaluation 1%
Intrinsic Value
Price
Base Case Scenario

Valuation Backtest
Castle Biosciences Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for CSTL cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about CSTL?
Bearish
Neutral
Bullish
Discover Undervalued Stocks
Health Care Industry

Fundamental Analysis

Risks & Rewards

 

 

 

 

View All Risks & Rewards
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Notes
AI Assistant
AI Assistant
Ask me anything about Castle Biosciences Inc

Provide an overview of the primary business activities
of Castle Biosciences Inc.

What unique competitive advantages
does Castle Biosciences Inc hold over its rivals?

What risks and challenges
does Castle Biosciences Inc face in the near future?

Summarize the latest earnings call
of Castle Biosciences Inc.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Castle Biosciences Inc.

Provide P/S
for Castle Biosciences Inc.

Provide P/E
for Castle Biosciences Inc.

Provide P/OCF
for Castle Biosciences Inc.

Provide P/FCFE
for Castle Biosciences Inc.

Provide P/B
for Castle Biosciences Inc.

Provide EV/S
for Castle Biosciences Inc.

Provide EV/GP
for Castle Biosciences Inc.

Provide EV/EBITDA
for Castle Biosciences Inc.

Provide EV/EBIT
for Castle Biosciences Inc.

Provide EV/OCF
for Castle Biosciences Inc.

Provide EV/FCFF
for Castle Biosciences Inc.

Provide EV/IC
for Castle Biosciences Inc.

Show me price targets
for Castle Biosciences Inc made by professional analysts.

What are the Revenue projections
for Castle Biosciences Inc?

How accurate were the past Revenue estimates
for Castle Biosciences Inc?

What are the Net Income projections
for Castle Biosciences Inc?

How accurate were the past Net Income estimates
for Castle Biosciences Inc?

What are the EPS projections
for Castle Biosciences Inc?

How accurate were the past EPS estimates
for Castle Biosciences Inc?

What are the EBIT projections
for Castle Biosciences Inc?

How accurate were the past EBIT estimates
for Castle Biosciences Inc?

Compare the revenue forecasts
for Castle Biosciences Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Castle Biosciences Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Castle Biosciences Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Castle Biosciences Inc compared to its peers.

Compare the P/E ratios
of Castle Biosciences Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Castle Biosciences Inc with its peers.

Analyze the financial leverage
of Castle Biosciences Inc compared to its main competitors.

Show all profitability ratios
for Castle Biosciences Inc.

Provide ROE
for Castle Biosciences Inc.

Provide ROA
for Castle Biosciences Inc.

Provide ROIC
for Castle Biosciences Inc.

Provide ROCE
for Castle Biosciences Inc.

Provide Gross Margin
for Castle Biosciences Inc.

Provide Operating Margin
for Castle Biosciences Inc.

Provide Net Margin
for Castle Biosciences Inc.

Provide FCF Margin
for Castle Biosciences Inc.

Show all solvency ratios
for Castle Biosciences Inc.

Provide D/E Ratio
for Castle Biosciences Inc.

Provide D/A Ratio
for Castle Biosciences Inc.

Provide Interest Coverage Ratio
for Castle Biosciences Inc.

Provide Altman Z-Score Ratio
for Castle Biosciences Inc.

Provide Quick Ratio
for Castle Biosciences Inc.

Provide Current Ratio
for Castle Biosciences Inc.

Provide Cash Ratio
for Castle Biosciences Inc.

What is the historical Revenue growth
over the last 5 years for Castle Biosciences Inc?

What is the historical Net Income growth
over the last 5 years for Castle Biosciences Inc?

What is the current Free Cash Flow
of Castle Biosciences Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Castle Biosciences Inc.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Castle Biosciences Inc

Current Assets 344.8m
Cash & Short-Term Investments 279.8m
Receivables 50.3m
Other Current Assets 14.7m
Non-Current Assets 169.8m
PP&E 56.3m
Intangibles 110.6m
Other Non-Current Assets 2.9m
Current Liabilities 44.3m
Accounts Payable 6.8m
Accrued Liabilities 34.5m
Other Current Liabilities 3m
Non-Current Liabilities 29.2m
Long-Term Debt 10.3m
Other Non-Current Liabilities 18.9m
Efficiency

Earnings Waterfall
Castle Biosciences Inc

Revenue
311.9m USD
Cost of Revenue
-56.4m USD
Gross Profit
255.4m USD
Operating Expenses
-256.5m USD
Operating Income
-1m USD
Other Expenses
7.1m USD
Net Income
6.1m USD

Free Cash Flow Analysis
Castle Biosciences Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

CSTL Profitability Score
Profitability Due Diligence

Castle Biosciences Inc's profitability score is 40/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Years Revenue Growth
Positive Gross Profit
ROIC is Increasing
Exceptional 1-Year Revenue Growth
40/100
Profitability
Score

Castle Biosciences Inc's profitability score is 40/100. The higher the profitability score, the more profitable the company is.

CSTL Solvency Score
Solvency Due Diligence

Castle Biosciences Inc's solvency score is 87/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Negative Net Debt
87/100
Solvency
Score

Castle Biosciences Inc's solvency score is 87/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

CSTL Price Targets Summary
Castle Biosciences Inc

Wall Street analysts forecast CSTL stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CSTL is 36.83 USD with a low forecast of 28.28 USD and a high forecast of 47.25 USD.

Lowest
Price Target
28.28 USD
11% Downside
Average
Price Target
36.83 USD
16% Upside
Highest
Price Target
47.25 USD
49% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for CSTL?

Click here to dive deeper.

Dividends

Castle Biosciences Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for CSTL is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

Castle Biosciences Inc Logo
Castle Biosciences Inc

Country

United States of America

Industry

Health Care

Market Cap

889.4m USD

Dividend Yield

0%

Description

Castle Biosciences, Inc. is a commercial-stage dermatological cancer company, which engages in the provision of genomic information for physicians and patients. The company is headquartered in Friendswood, Texas and currently employs 342 full-time employees. The company went IPO on 2019-07-25. The company is focused on providing physicians and their patients with personalized, clinically actionable information to clinicians and their patients to inform treatment decisions and improve health outcomes. The firm markets five multi-analyte assays with algorithmic analysis (MAAA) tests for use in the dermatologic, ocular and gastroenterology fields: DecisionDx-Melanoma, DecisionDx-SCC, Comprehensive Diagnostic Offering (CDO), DecisionDx-UM and TissueCypher Barrett’s Esophagus Assay. DecisionDx-Melanoma is risk stratification gene expression profile (GEP) test developed to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. DecisionDx-SCC, a 40-gene expression profile test that uses an individual patient’s tumor biology to predict individual risk of squamous cell carcinoma (SCC) metastasis for patients with one or more risk factors.

Contact

TEXAS
Friendswood
505 S Friendswood Drive, Suite 401
+18667889007.0
www.castlebiosciences.com

IPO

2019-07-25

Employees

342

Officers

Founder, CEO, President & Director
Mr. Derek J. Maetzold
CFO & Treasurer
Mr. Frank Stokes
Chief Operating Officer
Ms. Kristen M. Oelschlager R.N.
Chief Commercial Officer
Mr. Tobin W. Juvenal
Vice President of Investor Relations & Corporate Affairs
Camilla Zuckero
Vice President of Sales
Mr. Kevin Doman
Show More
VP of Human Resources & Executive Director of Human Resources
Ms. Keli Greenberg
Senior Vice President of Medical
Dr. Matthew Goldberg M.D.
Company Secretary
Mr. Bernhard E. Spiess
Show Less

See Also

Discover More
What is the Intrinsic Value of one CSTL stock?

The intrinsic value of one CSTL stock under the Base Case scenario is 32.02 USD.

Is CSTL stock undervalued or overvalued?

Compared to the current market price of 31.79 USD, Castle Biosciences Inc is Undervalued by 1%.

Back to Top